ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 164 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,602 | -69.6% | 73 | -50.0% | 0.00% | – |
Q2 2023 | $8,546 | +65.0% | 146 | +100.0% | 0.00% | – |
Q1 2023 | $5,179 | +32268.8% | 73 | -68.0% | 0.00% | – |
Q4 2022 | $16 | -99.8% | 228 | +60.6% | 0.00% | – |
Q3 2022 | $10,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q2 2022 | $10,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q1 2022 | $10,000 | – | 142 | +3450.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 4 | -71.4% | 0.00% | – |
Q1 2021 | $2,000 | -50.0% | 14 | -56.2% | 0.00% | – |
Q4 2020 | $4,000 | +300.0% | 32 | +220.0% | 0.00% | – |
Q3 2020 | $1,000 | – | 10 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | – | 14 | +250.0% | 0.00% | – |
Q3 2017 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 4 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 4 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 4 | -63.6% | 0.00% | – |
Q4 2015 | $1,000 | – | 11 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |